Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

Kono SA, Heasley LE, Doebele RC, Camidge DR.

Curr Cancer Drug Targets. 2012 Feb;12(2):107-23. Review.

2.

A Hypomorphic Allele in the FGF8 Gene Contributes to Holoprosencephaly and Is Allelic to Gonadotropin-Releasing Hormone Deficiency in Humans.

Arauz RF, Solomon BD, Pineda-Alvarez DE, Gropman AL, Parsons JA, Roessler E, Muenke M.

Mol Syndromol. 2010;1(2):59-66.

3.

The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer.

Kono SA, Marshall ME, Ware KE, Heasley LE.

Drug Resist Updat. 2009 Aug-Oct;12(4-5):95-102. doi: 10.1016/j.drup.2009.05.001. Review.

4.

Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer.

Zammit C, Coope R, Gomm JJ, Shousha S, Johnston CL, Coombes RC.

Br J Cancer. 2002 Apr 8;86(7):1097-103.

5.

Fibroblast growth factors.

Ornitz DM, Itoh N.

Genome Biol. 2001;2(3):REVIEWS3005. Review.

Supplemental Content

Support Center